Introduction Tavotek is a biopharmaceutical corporation dedicated to identifying, acquiring, developing, and commercializing therapeutic drugs for patients with severe diseases that lack effective medical treatments. The company's management team and advisors are composed of experienced pharmaceutical executives who have successfully developed numerous blockbuster biologics currently available on the market. Tavotek has three distinct research and development platforms for biologics: TavoSelect, TavoPrecise, and TavoMIP. In addition to these platforms, Tavotek has a diverse portfolio of product candidates in various stages of development, focusing on cancer, autoimmune disorders, and infectious diseases. |